| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.083 | 0.6 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.089 | 0.6 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |